Market Overview:
The global pancreatic cancer therapy market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of pancreatic cancer, rising demand for better treatment options, and technological advancements in the field of pancreatic cancer therapy. Based on type, the global pancreatic cancer therapy market is segmented into biology, chemotherapy, targeted therapy, and others. Biology-based therapies are further classified into immunotherapy and gene therapy. Chemotherapy-based therapies are further classified into traditional chemotherapy and novel chemotherapies. Targeted therapies are further classified into small molecule inhibitors and monoclonal antibodies (mAbs). Others include radiation therapy and hormone therapy. Based on application, the global pancreatic cancer Therapy market is segmented into hospitals, clinics, research institutes & academic centers),and others including home care settings & palliative care centers . Hospitals held a dominant share in 2017 owing to increased use of expensive treatments such as targeted therapies and novel chemotherapies in this setting coupled with growing number of patients diagnosed with advanced stage tumors that require hospitalization for treatment. However , clinics are projected to witness highest growth during the forecast period due to increasing preference for outpatient care among patients suffering from early stage tumors .
Product Definition:
Pancreatic cancer therapy is the treatment of tumors that form in the pancreas. The pancreas is a gland located behind the stomach that produces hormones and enzymes that help digest food. Pancreatic cancer therapy includes surgery, radiation therapy, and chemotherapy.
Biology:
Biology is the study of living organisms. It includes their structure, function, growth & development and their interaction with the environment. The application of biology in clinical oncology is growing rapidly due to its advantages such as it's a natural science; it studies cause and effect at the molecular level; it provides a holistic approach to understanding disease progression; and lastly, most biologic therapies have been proven effective for pancreatic cancer which I will cover later on in this article.
Chemotherapy:
Chemotherapy is the use of drugs or chemical substances to treat cancer. Chemotherapy includes a group of medical treatments used for the treatment and prevention of cancer. The major types of chemotherapies include alkylating agents, cytotoxic agents, plant derivatives, and others. The most common type used today is chemotherapy with radiation therapy if needed followed by surgery or radiofrequency ablation (RFA) if possible.
Application Insights:
The others segment held the largest share of the global pancreatic cancer therapy market in 2017. This segment includes surgical treatment, radiation therapy, and chemotherapy. The others segment dominated the market by application as it is a more economical and less invasive way to treat this disease than other methods such as surgery or chemotherapy. However, hospitals held a larger share of the overall revenue in 2017 due to an increase in spending on healthcare services by companies & organizations.
Hospitals are considered to be one of the best places for diagnosis and treatment of diseases owing to advanced medical equipment available there along with experienced staff who can assist patients with their queries regarding any health issue they may have.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, increased R&D investment by companies and government initiatives undertaken for Pancreatic Cancer Awareness Month in October. In addition, increasing cases of obesity and diabetes are also contributing towards growth. According to a study published by National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK), about 30% population in U.S., aged 20 or more years was suffering from diabetes as per 2015 survey data.
Growth Factors:
- Increasing incidence of pancreatic cancer
- Growing demand for better treatment options for pancreatic cancer patients
- Rising awareness about pancreatic cancer and its symptoms
- Technological advancements in the field of pancreatic cancer therapy
- Availability of government funding for research on pancreatic cancer
Scope Of The Report
Report Attributes
Report Details
Report Title
Pancreatic Cancer Therapy Market Research Report
By Type
Biology, Chemotherapy, Targeted Therapy, Others
By Application
Hospitals, Clinics, Others
By Companies
Eli Lilly, Roche, Pfizer, Merck, Celgene, Novartis, Amgen, Teva Pharmaceutical, PharmaCyte Biotech, Clovis Oncology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
211
Number of Tables & Figures
148
Customization Available
Yes, the report can be customized as per your need.
Global Pancreatic Cancer Therapy Market Report Segments:
The global Pancreatic Cancer Therapy market is segmented on the basis of:
Types
Biology, Chemotherapy, Targeted Therapy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Eli Lilly
- Roche
- Pfizer
- Merck
- Celgene
- Novartis
- Amgen
- Teva Pharmaceutical
- PharmaCyte Biotech
- Clovis Oncology
Highlights of The Pancreatic Cancer Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biology
- Chemotherapy
- Targeted Therapy
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pancreatic Cancer Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pancreatic cancer therapy is the treatment of pancreatic cancer with surgery, chemotherapy, and radiation.
Some of the major players in the pancreatic cancer therapy market are Eli Lilly, Roche, Pfizer, Merck, Celgene, Novartis, Amgen, Teva Pharmaceutical, PharmaCyte Biotech, Clovis Oncology.
The pancreatic cancer therapy market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pancreatic Cancer Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pancreatic Cancer Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pancreatic Cancer Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pancreatic Cancer Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pancreatic Cancer Therapy Market Size & Forecast, 2020-2028
4.5.1 Pancreatic Cancer Therapy Market Size and Y-o-Y Growth
4.5.2 Pancreatic Cancer Therapy Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Biology
5.2.2 Chemotherapy
5.2.3 Targeted Therapy
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pancreatic Cancer Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pancreatic Cancer Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Biology
9.6.2 Chemotherapy
9.6.3 Targeted Therapy
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Biology
10.6.2 Chemotherapy
10.6.3 Targeted Therapy
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Biology
11.6.2 Chemotherapy
11.6.3 Targeted Therapy
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Biology
12.6.2 Chemotherapy
12.6.3 Targeted Therapy
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Biology
13.6.2 Chemotherapy
13.6.3 Targeted Therapy
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pancreatic Cancer Therapy Market: Competitive Dashboard
14.2 Global Pancreatic Cancer Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Eli Lilly
14.3.2 Roche
14.3.3 Pfizer
14.3.4 Merck
14.3.5 Celgene
14.3.6 Novartis
14.3.7 Amgen
14.3.8 Teva Pharmaceutical
14.3.9 PharmaCyte Biotech
14.3.10 Clovis Oncology
